Resources

Amylin and Eli Lilly announced results from the first double-blind, placebo-controlled clinical study to evaluate BYETTAA® (exenatide) injection added to Lantus® (insulin glargine)…. 

Amylin and Lilly announced the results of another study, comparing the effect of long-term treatment with either BYETTA® (exenatide) injection or Lantus® (insulin glargine) on overall beta-cell function. Three years of BYETTA therapy improved indices of beta-cell function assessed four weeks after discontinuing therapy….

Data from nearly 1,100 patients in DURATION-1, -2 and -3 trials showed BYDUREON was well-tolerated….

New clinical study shows patients with Type 2 diabetes may be able to tolerate higher doses of metformin using GLUMETZA…. 

2010 Product Spotlight Our once-a-year special edition of Product Spotlight is now available. Follow this link to the 2010 Product Spotlight to check out the latest products advancing diabetes care.

African Americans have higher levels of glycated hemoglobin (HbA1c) than whites given the same blood glucose concentrations, and the difference is greater as glucose levels go up. Findings could affect the way physicians use hemoglobin A1c to test for diabetes in blacks…. 

Although the liver is often overlooked in diabetes, even newly-diagnosed cases carry a substantial risk of serious hepatic damage, researchers found….

To avoid Type 2 diabetes, seniors may need to watch their weight just as closely as younger individuals do, a prospective cohort study showed….

Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds…. 

Adolescent blood pressure (BP) predicts progression to hypertension in young adulthood, with teen-age boys with normal BP 3 to 4 times more likely than girls to have high BP early in adulthood, according to the results of a study….